ACUTE MYELOMONOCYTIC LEUKAEMIA

This adverse event was reported 252 times

These drugs are most commonly taken by patients reporting ACUTE MYELOMONOCYTIC LEUKAEMIA:

# Drug Count
0 CYCLOPHOSPHAMIDE 80
1 CYCLOPHOSPHAMIDE FOR INJECTION 80
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 80
3 PREDNISONE 37
4 DOXORUBICIN 33
5 ETOPOSIDE 32
6 METHOTREXATE SODIUM 32
7 METHOTREXATE 28
8 RITUXIMAB 28
9 CARBOPLATIN 24
See all common drugs associated with ACUTE MYELOMONOCYTIC LEUKAEMIA

ACUTE MYELOMONOCYTIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBRITUMOMAB TIUXETAN 4 0.0026
1 ETOPOSIDE PHOSPHATE 4 0.0024
2 DACARBAZINE 15 0.0020
3 CHLORAMBUCIL 7 0.0018
4 MITOXANTRONE HYDROCHLORIDE 11 0.0017
5 BLEOMYCIN SULFATE 16 0.0015
6 CABAZITAXEL 4 0.0011
7 EPIRUBICIN HYDROCHLORIDE 5 0.0008
8 BLINATUMOMAB 6 0.0006
9 VINCRISTINE SULFATE 15 0.0005
See all drugs enriched for association with ACUTE MYELOMONOCYTIC LEUKAEMIA